Idiopathic pulmonary fibrosis

References

• Katzenstein A, Myers J. Idiopathic pulmonary fibrosis. Clinical relevance of pathological classification. Am. J. Respir. Crit. Care Med.157, 1301–1315 (1998).
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am. J. Respir. Crit. Care Med.161(2 Pt 1), 646–664 (2000).
   PubMed Web of Science ®Google Scholar
• Lynch JP 3rd, Saggar R, Weigt SS, Zisman DA, White ES. Usual interstitial pneumonia. Semin. Respir. Crit. Care Med.27(6), 634–651 (2006).
   PubMed Web of Science ®Google Scholar
• Park JH, Kim DS, Park IN et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am. J. Respir. Crit. Care Med.175(7), 705–711 (2007).
   PubMed Web of Science ®Google Scholar
• American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med.165(2), 277–304 (2002).
   PubMedGoogle Scholar
• Lai CK, Wallace WD, Fishbein MC. Histopathology of pulmonary fibrotic disorders. Semin. Respir. Crit. Care Med.27(6), 613–622 (2006).
   PubMed Web of Science ®Google Scholar
• Misumi S, Lynch DA. Idiopathic pulmonary fibrosis/usual interstitial pneumonia: imaging diagnosis, spectrum of abnormalities, and temporal progression. Proc. Am. Thorac. Soc.3(4), 307–314 (2006).
   PubMedGoogle Scholar
• Flaherty KR, Thwaite EL, Kazerooni EA et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax58(2), 143–148 (2003).
   PubMed Web of Science ®Google Scholar
• Bjoraker JA, Ryu JH, Edwin MK et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med.157(1), 199–203 (1998).
   PubMed Web of Science ®Google Scholar
• Flaherty KR, Travis WD, Colby TV et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am. J. Respir. Crit. Care Med.164(9), 1722–1727 (2001).
   PubMed Web of Science ®Google Scholar
• Monaghan H, Wells AU, Colby TV, du Bois RM, Hansell DM, Nicholson AG. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest125(2), 522–526 (2004).
   PubMed Web of Science ®Google Scholar
• Nicholson AG, Wells AU. Nonspecific interstitial pneumonia – nobody said it’s perfect. Am. J. Respir. Crit. Care Med.164(9), 1553–1554 (2001).
   PubMed Web of Science ®Google Scholar
• Nicholson AG, Fulford LG, Colby TV, du Bois RM, Hansell DM, Wells AU. The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med.166(2), 173–177 (2002).
   PubMed Web of Science ®Google Scholar
• Nicholson AG, Colby TV, du Bois RM, Hansell DM, Wells AU. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am. J. Respir. Crit. Care Med.162(6), 2213–2217 (2000).
   PubMed Web of Science ®Google Scholar
• Travis WD, Matsui K, Moss J, Ferrans VJ. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am. J. Surg. Pathol.24(1), 19–33 (2000).
   PubMed Web of Science ®Google Scholar
• Visscher DW, Myers JL. Histologic spectrum of idiopathic interstitial pneumonias. Proc. Am. Thorac. Soc.3(4), 322–329 (2006).
   PubMedGoogle Scholar
• Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am. J. Surg. Pathol.18(2), 136–147 (1994).
   PubMed Web of Science ®Google Scholar
• Bouros D, Nicholson AC, Polychronopoulos V, du Bois RM. Acute interstitial pneumonia. Eur. Respir. J.15(2), 412–418 (2000).
   PubMed Web of Science ®Google Scholar
• Lynch DA, Newell JD, Logan PM, King TE Jr, Muller NL. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? AJR Am. J. Roentgenol.165(4), 807–811 (1995).
   PubMed Web of Science ®Google Scholar
• Flaherty KR, Toews GB, Travis WD et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur. Respir. J.19(2), 275–283 (2002).
   PubMed Web of Science ®Google Scholar
• Katzenstein AL, Zisman DA, Litzky LA, Nguyen BT, Kotloff RM. Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am. J. Surg. Pathol.26(12), 1567–1577 (2002).
   PubMed Web of Science ®Google Scholar
• Flaherty KR, Mumford JA, Murray S et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am. J. Respir. Crit. Care Med.168(5), 543–548 (2003).
   PubMed Web of Science ®Google Scholar
• Latsi PI, du Bois RM, Nicholson AG et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am. J. Respir. Crit. Care Med.168(5), 531–537 (2003).
   PubMed Web of Science ®Google Scholar
• Nagai S, Kitaichi M, Itoh H, Nishimura K, Izumi T, Colby T. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur. Respir. J.12, 1010–1019 (1998).
   PubMed Web of Science ®Google Scholar
• Thannickal VJ, Flaherty KR, Martinez FJ, Lynch JP 3rd. Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy. Expert Opin. Pharmacother.5(8), 1671–1686 (2004).
   PubMed Web of Science ®Google Scholar
• Thannickal VJ, Flaherty KR, Hyzy RC, Lynch JP 3rd. Emerging drugs for idiopathic pulmonary fibrosis. Expert Opin. Emerg. Drugs10(4), 707–727 (2005).
   PubMedGoogle Scholar
• Selman M, Thannickal VJ, Pardo A, Zisman DA, Martinez FJ, Lynch JP 3rd. Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs64(4), 405–430 (2004).
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Flaherty K. Pulmonary function testing in idiopathic interstitial pneumonias. Proc. Am. Thorac. Soc.3(4), 315–321 (2006).
   PubMedGoogle Scholar
• Yokoyama A, Kondo K, Nakajima M et al. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology11(2), 164–168 (2006).
   PubMed Web of Science ®Google Scholar
• Greene KE, King TE Jr, Kuroki Y et al. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur. Respir. J.19(3), 439–446 (2002).
   PubMed Web of Science ®Google Scholar
• Takahashi H, Shiratori M, Kanai A, Chiba H, Kuroki Y, Abe S. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D. Respirology11(Suppl.), S51–S54 (2006).
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Safrin S, Weycker D et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann. Intern. Med.142(12 Pt 1), 963–967 (2005).
   PubMed Web of Science ®Google Scholar
• Douglas WW, Ryu JH, Schroeder DR. Idiopathic pulmonary fibrosis: impact of oxygen and colchicine, prednisone, or no therapy on survival. Am. J. Respir. Crit. Care Med.161, 1172–1178 (2000).
   PubMed Web of Science ®Google Scholar
• Collard HR, King TE Jr, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med.168(5), 538–542 (2003).
   PubMed Web of Science ®Google Scholar
• Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax61(11), 980–985 (2006).
   PubMed Web of Science ®Google Scholar
• Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am. J. Respir. Crit. Care Med.150(4), 967–972 (1994).
   PubMed Web of Science ®Google Scholar
• Hubbard R, Johnston I, Coultas DB, Britton J. Mortality rates from cryptogenic fibrosing alveolitis in seven countries. Thorax51(7), 711–716 (1996).
   PubMed Web of Science ®Google Scholar
• Scott J, Johnston I, Britton J. What causes cryptogenic fibrosing alveolitis? A case–control study of environmental exposure to dust. BMJ301(6759), 1015–1017 (1990).
   PubMedGoogle Scholar
• Harris JM, Cullinan P, McDonald JC. Occupational distribution and geographic clustering of deaths certified to be cryptogenic fibrosing alveolitis in England and Wales. Chest119(2), 428–433 (2001).
   PubMed Web of Science ®Google Scholar
• Iwai K, Mori T, Yamada N, Yamaguchi M, Hosoda Y. Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. Am. J. Respir. Crit. Care Med.150(3), 670–675 (1994).
   PubMed Web of Science ®Google Scholar
• Mannino DM, Etzel RA, Parrish RG. Pulmonary fibrosis deaths in the United States, 1979–1991. An analysis of multiple-cause mortality data. Am. J. Respir. Crit. Care Med.153(5), 1548–1552 (1996).
   PubMed Web of Science ®Google Scholar
• Johnston ID, Prescott RJ, Chalmers JC, Rudd RM. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. Thorax52(1), 38–44 (1997).
   PubMed Web of Science ®Google Scholar
• Thomas AQ, Lane K, Phillips J 3rd et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am. J. Respir. Crit. Care Med.165(9), 1322–1328 (2002).
   PubMed Web of Science ®Google Scholar
• Fan LL, Kozinetz CA. Factors influencing survival in children with chronic interstitial lung disease. Am. J. Respir. Crit. Care Med.156(3 Pt 1), 939–942 (1997).
   PubMed Web of Science ®Google Scholar
• Taskar VS, Coultas DB. Is idiopathic pulmonary fibrosis an environmental disease? Proc. Am. Thorac. Soc.3(4), 293–298 (2006).
   PubMedGoogle Scholar
• Billings CG, Howard P. Hypothesis: exposure to solvents may cause fibrosing alveolitis. Eur. Respir. J.7(6), 1172–1176 (1994).
   PubMed Web of Science ®Google Scholar
• Tobin RW, Pope CE 2nd, Pellegrini CA, Emond MJ, Sillery J, Raghu G. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med.158(6), 1804–1808 (1998).
   PubMed Web of Science ®Google Scholar
• Raghu G, Freudenberger TD, Yang S et al. High prevalence of abnormal acid gastro–oesophageal reflux in idiopathic pulmonary fibrosis. Eur. Respir. J.27(1), 136–142 (2006).
   PubMed Web of Science ®Google Scholar
• Sweet MP, Patti MG, Leard LE et al. Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation. J. Thorac. Cardiovasc. Surg.133(4), 1078–1084 (2007).
   PubMed Web of Science ®Google Scholar
• Raghu G, Yang ST, Spada C, Hayes J, Pellegrini CA. Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series. Chest129(3), 794–800 (2006).
   PubMed Web of Science ®Google Scholar
• Patti MG, Tedesco P, Golden J et al. Idiopathic pulmonary fibrosis: how often is it really idiopathic? J. Gastrointest. Surg.9(8), 1053–1058 (2005).
   PubMed Web of Science ®Google Scholar
• D’Ovidio F, Singer LG, Hadjiliadis D et al. Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant. Ann. Thorac. Surg.80(4), 1254–1260 (2005).
   PubMed Web of Science ®Google Scholar
• Sweet MP, Herbella FA, Leard L et al. The prevalence of distal and proximal gastroesophageal reflux in patients awaiting lung transplantation. Ann. Surg.244(4), 491–497 (2006).
   PubMed Web of Science ®Google Scholar
• du Bois RM. Genetic factors in pulmonary fibrotic disorders. Semin. Respir. Crit. Care Med.27(6), 581–588 (2006).
   PubMed Web of Science ®Google Scholar
• Steele MP, Speer MC, Loyd JE et al. Clinical and pathologic features of familial interstitial pneumonia. Am. J. Respir. Crit. Care Med.172(9), 1146–1152 (2005).
   PubMed Web of Science ®Google Scholar
• Grutters JC, du Bois RM. Genetics of fibrosing lung diseases. Eur. Respir. J.25(5), 915–927 (2005).
   PubMed Web of Science ®Google Scholar
• Armanios MY, Chen JJ, Cogan JD et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med.356(13), 1317–1326 (2007).
   PubMed Web of Science ®Google Scholar
• Marshall RP, Puddicombe A, Cookson WO, Laurent GJ. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax55(2), 143–146 (2000).
   PubMed Web of Science ®Google Scholar
• Loyd JE. Pulmonary fibrosis in families. Am. J. Respir. Cell. Mol. Biol.29(3 Suppl.), S47–S50 (2003).
   PubMed Web of Science ®Google Scholar
• Doherty MJ, Pearson MG, O’Grady EA, Pellegrini V, Calverley PM. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax52(11), 998–1002 (1997).
   PubMed Web of Science ®Google Scholar
• Cottin V, Nunes H, Brillet PY et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur. Respir. J.26(4), 586–593 (2005).
   PubMed Web of Science ®Google Scholar
• King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am. J. Respir. Crit. Care Med.164(7), 1171–1181 (2001).
   PubMed Web of Science ®Google Scholar
• Cherniack RM, Colby TV, Flint A et al. Correlation of structure and function in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med.151(4), 1180–1188 (1995).
   PubMed Web of Science ®Google Scholar
• Daniil ZD, Gilchrist FC, Nicholson AG et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am. J. Respir. Crit. Care Med.160(3), 899–905 (1999).
   PubMed Web of Science ®Google Scholar
• Lama VN, Flaherty KR, Toews GB et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am. J. Respir. Crit. Care Med.168(9), 1084–1090 (2003).
   PubMed Web of Science ®Google Scholar
• Hallstrand TS, Boitano LJ, Johnson WC, Spada CA, Hayes JG, Raghu G. The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur. Respir. J.25(1), 96–103 (2005).
   PubMed Web of Science ®Google Scholar
• Flaherty KR, Andrei AC, Murray S et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am. J. Respir. Crit. Care Med.174(7), 803–809 (2006).
   PubMed Web of Science ®Google Scholar
• Hubbard R, Johnston I, Britton J. Survival in patients with cryptogenic fibrosing alveolitis. A population-based cohort study. Chest113, 396–400 (1998).
   PubMed Web of Science ®Google Scholar
• Mogulkoc N, Brutsche MH, Bishop PW, Greaves SM, Horrocks AW, Egan JJ. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am. J. Respir. Crit. Care Med.164(1), 103–108 (2001).
   PubMed Web of Science ®Google Scholar
• King TE Jr, Safrin S, Starko KM et al. Analyses of efficacy end points in a controlled trial of interferon-γ1b for idiopathic pulmonary fibrosis. Chest127(1), 171–177 (2005).
   PubMed Web of Science ®Google Scholar
• Jegal Y, Kim DS, Shim TS et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am. J. Respir. Crit. Care Med.171(6), 639–644 (2005).
   PubMed Web of Science ®Google Scholar
• Raghu G, Brown KK, Bradford WZ et al. A placebo-controlled trial of interferon γ-1b in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med.350(2), 125–133 (2004).
   PubMed Web of Science ®Google Scholar
• Lynch DA, Godwin JD, Safrin S et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am. J. Respir. Crit. Care Med.172(4), 488–493 (2005).
   PubMed Web of Science ®Google Scholar
• Flaherty KR, Toews GB, Lynch JP 3rd et al. Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. Am. J. Med.110(4), 278–282 (2001).
   PubMed Web of Science ®Google Scholar
• Kawut SM, O’Shea MK, Bartels MN, Wilt JS, Sonett JR, Arcasoy SM. Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. Respir. Med.99(11), 1431–1439 (2005).
   PubMed Web of Science ®Google Scholar
• Lederer DJ, Arcasoy SM, Wilt JS, D’Ovidio F, Sonett JR, Kawut SM. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med.174(6), 659–664 (2006).
   PubMed Web of Science ®Google Scholar
• Eaton T, Young P, Milne D, Wells AU. Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am. J. Respir. Crit. Care Med.171(10), 1150–1157 (2005).
   PubMed Web of Science ®Google Scholar
• Elliot TL, Lynch DA, Newell JD Jr et al. High-resolution computed tomography features of nonspecific interstitial pneumonia and usual interstitial pneumonia. J. Comput. Assist. Tomogr.29(3), 339–345 (2005).
   PubMed Web of Science ®Google Scholar
• Xaubet A, Agusti C, Luburich P et al. Pulmonary function tests and CT scan in the management of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med.158, 431–436 (1998).
   PubMed Web of Science ®Google Scholar
• Sumikawa H, Johkoh T, Ichikado K et al. Usual interstitial pneumonia and chronic idiopathic interstitial pneumonia: analysis of CT appearance in 92 patients. Radiology241(1), 258–266 (2006).
   PubMed Web of Science ®Google Scholar
• MacDonald SL, Rubens MB, Hansell DM et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology221(3), 600–605 (2001).
   PubMed Web of Science ®Google Scholar
• Hunninghake GW, Lynch DA, Galvin JR et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest124(4), 1215–1223 (2003).
   PubMed Web of Science ®Google Scholar
• Souza CA, Muller NL, Lee KS, Johkoh T, Mitsuhiro H, Chong S. Idiopathic interstitial pneumonias: prevalence of mediastinal lymph node enlargement in 206 patients. AJR Am. J. Roentgenol.186(4), 995–999 (2006).
   PubMed Web of Science ®Google Scholar
• Franquet T, Gimenez A, Alegret X, Rodriguez-Arias JM. Mediastinal lymphadenopathy in cryptogenic fibrosing alveolitis: the effect of steroid therapy on the prevalence of nodal enlargement. Clin. Radiol.53(6), 435–438 (1998).
   PubMed Web of Science ®Google Scholar
• Wells AU, Hansell DM, Rubens MB, Cailes JB, Black CM, du Bois RM. Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison. Am. J. Respir. Crit. Care Med.155(5), 1657–1664 (1997).
   PubMed Web of Science ®Google Scholar
• Wells AU, King AD, Rubens MB, Cramer D, du Bois RM, Hansell DM. Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography. Am. J. Respir. Crit. Care Med.155(4), 1367–1375 (1997).
   PubMed Web of Science ®Google Scholar
• Brantly M, Avila NA, Shotelersuk V, Lucero C, Huizing M, Gahl WA. Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky–Pudlak syndrome, due to mutations in HPS-1. Chest117(1), 129–136 (2000).
   PubMed Web of Science ®Google Scholar
• Wells AU, Rubens MB, du Bois RM, Hansell DM. Functional impairment in fibrosing alveolitis: relationship to reversible disease on thin section computed tomography. Eur. Respir. J.10(2), 280–285 (1997).
   PubMed Web of Science ®Google Scholar
• Hartman TE, Primack SL, Kang EY et al. Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia. Assessment with serial CT. Chest110(2), 378–382 (1996).
   PubMed Web of Science ®Google Scholar
• Gay SE, Kazerooni EA, Toews GB et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am. J. Respir. Crit. Care Med.157(4 Pt 1), 1063–1072 (1998).
   PubMed Web of Science ®Google Scholar
• Wells AU, Desai SR, Rubens MB et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am. J. Respir. Crit. Care Med.167(7), 962–969 (2003).
   PubMed Web of Science ®Google Scholar
• Watters LC, King TE, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis.133(1), 97–103 (1986).
   PubMed Web of Science ®Google Scholar
• Ryu YJ, Chung MP, Han J et al. Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias. Respir. Med.101(3), 655–660 (2007).
   PubMed Web of Science ®Google Scholar
• Drent M, van Nierop MA, Gerritsen FA, Wouters EF, Mulder PG. A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases. Am. J. Respir. Crit. Care Med.153(2), 736–741 (1996).
   PubMed Web of Science ®Google Scholar
• Meissner HH, Soo Hoo GW, Khonsary SA, Mandelkern M, Brown CV, Santiago SM. Idiopathic pulmonary fibrosis: evaluation with positron emission tomography. Respiration73(2), 197–202 (2006).
   PubMed Web of Science ®Google Scholar
• Nadrous HF, Pellikka PA, Krowka MJ et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest128(4), 2393–2399 (2005).
   PubMed Web of Science ®Google Scholar
• Ghofrani HA, Wiedemann R, Rose F et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet360(9337), 895–900 (2002).
   PubMed Web of Science ®Google Scholar
• Nathan SD, Noble PW, Tuder RM. Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. Am. J. Respir. Crit. Care Med.175(9), 875–880 (2007).
   PubMed Web of Science ®Google Scholar
• Nathan SD, Shlobin OA, Ahmad S, Urbanek S, Barnett SD. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest131(3), 657–663 (2007).
   PubMed Web of Science ®Google Scholar
• Zisman DA, Ross DJ, Belperio JA et al. Prediction of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir. Med.101, 2153–2159 (2007).
   PubMed Web of Science ®Google Scholar
• Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest129(3), 746–752 (2006).
   PubMed Web of Science ®Google Scholar
• Arcasoy SM, Christie JD, Ferrari VA et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am. J. Respir. Crit. Care Med.167(5), 735–740 (2003).
   PubMed Web of Science ®Google Scholar
• Zisman DA, Karlamangla AS, Ross DJ et al. High-resolution chest computed tomography findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest132, 773–779 (2007).
   PubMed Web of Science ®Google Scholar
• Galie N, Ghofrani HA, Torbicki A et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N. Engl. J. Med.353(20), 2148–2157 (2005).
   PubMed Web of Science ®Google Scholar
• Collard HR, Anstrom KJ, Schwarz MI, Zisman DA. Sildenafil improves walk distance in idiopathic pulmonary fibrosis. Chest131(3), 897–899 (2007).
   PubMed Web of Science ®Google Scholar
• Rubin LJ, Badesch DB, Barst RJ et al. Bosentan therapy for pulmonary arterial hypertension. N. Engl. J. Med.346(12), 896–903 (2002).
   PubMed Web of Science ®Google Scholar
• Daniels CE, Ryu JH. Treatment of idiopathic pulmonary fibrosis. Semin. Respir. Crit. Care Med.27(6), 668–676 (2006).
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E et al. Cancer statistics, 2006. CA Cancer J. Clin.56(2), 106–130 (2006).
   PubMed Web of Science ®Google Scholar
• Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am. J. Respir. Crit. Care Med.161(1), 5–8 (2000).
   PubMed Web of Science ®Google Scholar
• Kumar P, Goldstraw P, Yamada K et al. Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. J. Thorac. Cardiovasc. Surg.125(6), 1321–1327 (2003).
   PubMed Web of Science ®Google Scholar
• Kawasaki H, Nagai K, Yoshida J, Nishimura M, Nishiwaki Y. Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis. J. Surg. Oncol.81(1), 33–37 (2002).
   PubMed Web of Science ®Google Scholar
• Vourlekis JS, Brown KK, Cool CD et al. Acute interstitial pneumonitis. Case series and review of the literature. Medicine (Baltimore)79(6), 369–378 (2000).
   Google Scholar
• Swigris JJ, Brown KK. Acute interstitial pneumonia and acute exacerbations of idiopathic pulmonary fibrosis. Semin. Respir. Crit. Care Med.27(6), 659–667 (2006).
   PubMed Web of Science ®Google Scholar
• Parambil JG, Myers JL, Ryu JH. Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest128(5), 3310–3315 (2005).
   PubMed Web of Science ®Google Scholar
• Kim DS, Park JH, Park BK, Lee JS, Nicholson AG, Colby T. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur. Respir. J.27(1), 143–150 (2006).
   PubMed Web of Science ®Google Scholar
• Churg A, Muller NL, Silva CI, Wright JL. Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am. J. Surg. Pathol.31(2), 277–284 (2007).
   PubMed Web of Science ®Google Scholar
• Collard HR, Moore BB, Flaherty KR et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med.176(7), 636–643 (2007).
   PubMed Web of Science ®Google Scholar
• Ambrosini V, Cancellieri A, Chilosi M et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur. Respir. J.22(5), 821–826 (2003).
   PubMed Web of Science ®Google Scholar
• Frutos-Vivar F, Ferguson ND, Esteban A. Epidemiology of acute lung injury and acute respiratory distress syndrome. Semin. Respir. Crit. Care Med.27(4), 327–336 (2006).
   PubMed Web of Science ®Google Scholar
• Rice AJ, Wells AU, Bouros D et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias. An autopsy study. Am. J. Clin. Pathol.119(5), 709–714 (2003).
   PubMed Web of Science ®Google Scholar
• Al-Hameed FM, Sharma S. Outcome of patients admitted to the intensive care unit for acute exacerbation of idiopathic pulmonary fibrosis. Can. Respir. J.11(2), 117–122 (2004).
   PubMedGoogle Scholar
• Suh GY, Kang EH, Chung MP et al. Early intervention can improve clinical outcome of acute interstitial pneumonia. Chest129(3), 753–761 (2006).
   PubMed Web of Science ®Google Scholar
• Zisman DA, Lynch JP 3rd, Toews GB, Kazerooni EA, Flint A, Martinez FJ. Cyclophosphamide in the treatment of idiopathic pulmonary fibrosis: a prospective study in patients who failed to respond to corticosteroids. Chest117(6), 1619–1626 (2000).
   PubMed Web of Science ®Google Scholar
• Lynch JP 3rd, White E, Flaherty K. Corticosteroids in idiopathic pulmonary fibrosis. Curr. Opin. Pulm. Med.7(5), 298–308 (2001).
   PubMedGoogle Scholar
• Lynch JP III, McCune WJ. Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders. Am. J. Respir. Crit. Care Med.155(2), 395–420 (1997).
   PubMed Web of Science ®Google Scholar
• Demedts M, Behr J, Buhl R et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N. Engl. J. Med.353(21), 2229–2242 (2005).
   PubMed Web of Science ®Google Scholar
• Azuma A, Nukiwa T, Tsuboi E et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med.171(9), 1040–1047 (2005).
   PubMed Web of Science ®Google Scholar
• Kubo H, Nakayama K, Yanai M et al. Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest128(3), 1475–1482 (2005).
   PubMed Web of Science ®Google Scholar
• Schermuly RT, Dony E, Ghofrani HA et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. J. Clin. Invest.115(10), 2811–2821 (2005).
   PubMed Web of Science ®Google Scholar
• Ask K, Martin GE, Kolb M, Gauldie J. Targeting genes for treatment in idiopathic pulmonary fibrosis: challenges and opportunities, promises and pitfalls. Proc. Am. Thorac. Soc.3(4), 389–393 (2006).
   PubMedGoogle Scholar
• Nathan SD, Saggar R, Lynch JP III. Lung transplantation for interstitial lung disorders. In: Lung and Heart–Lung Transplantation. Lynch JP III, Ross D (Eds). Taylor and Francis, NY, USA 217, 165–204 (2006).
   Google Scholar
• International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation (ISHLT). Am. J. Respir. Crit. Care Med.158(1), 335–339 (1998).
   PubMed Web of Science ®Google Scholar
• Meyer DM, Edwards LB, Torres F, Jessen ME, Novick RJ. Impact of recipient age and procedure type on survival after lung transplantation for pulmonary fibrosis. Ann. Thorac. Surg.79(3), 950–958 (2005).
   PubMed Web of Science ®Google Scholar
• Lynch JP 3rd, Saggar R, Weigt SS, Ross DJ, Belperio JA. Overview of lung transplantation and criteria for selection of candidates. Semin. Respir. Crit. Care Med.27(5), 441–469 (2006).
   PubMed Web of Science ®Google Scholar